INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 46430
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 24225
 
 
 
C07K PEPTIDES 24013
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 19456
 
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 14128
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 8232
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 4353
 
 
 
C07D HETEROCYCLIC COMPOUNDS 39123
 
 
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 3762
 
 
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 36204

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0071,413 NON-INVASIVE IMAGING OF TUMOR PD-L1 EXPRESSIONApr 06, 16Mar 15, 18[A61K, C07K]
2018/0064,789 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PANCREATIC CANCERNov 21, 17Mar 08, 18[G01N, A61K, C07K]
2018/0064,825 ANTI-PD-L1 IMMUNOTOXIN FOR USE IN THERAPYApr 06, 16Mar 08, 18[A61K, C07K]
2018/0066,241 PRO-APOPTOTIC SET AND PP2A PEPTIDESMar 31, 16Mar 08, 18[C12N, C07K]
2018/0057,812 HEPCIDIN ANTAGONISTS FOR USE IN THE TREATMENT OF INFLAMMATIONMar 14, 16Mar 01, 18[C12N, C07K]
2018/0063,506 METHOD FOR THE 3D RECONSTRUCTION OF A SCENEMar 15, 16Mar 01, 18[H04N]
2018/0042,937 NOVEL ANTIVIRAL COMPOSITIONS FOR TREATING THE FLUMar 18, 16Feb 15, 18[A61K]
2018/0036,368 COMBINED VACCINATION/RADIOTERAPY FOR CANCER TREATMENTFeb 20, 16Feb 08, 18[A61N, A61K]
2018/0037,612 VACCINES FOR PREVENTING MENINGOCOCCAL INFECTIONSSep 13, 17Feb 08, 18[A61K, C07K]
2018/0021,302 PTGDR-1 AND/OR PTGDR-2 ANTAGONISTS FOR PREVENTING AND/OR TREATING SYSTEMIC LUPUS ERYTHEMATOSUSFeb 12, 16Jan 25, 18[A61K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9919029 Methods and pharmaceutical compositions for the treatment of bacterial infectionsJul 25, 14Mar 20, 18[A61K]
9920103 Preparation of recombinant human plasma phospholipid transfer protein (PLTP) from the milk of transgenic rabbitsApr 06, 11Mar 20, 18[C12N, A01K, C07K]
9913829 Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compoundJul 29, 11Mar 13, 18[A61K]
9909977 Simultaneous monitoring of fibrinogen and haematocrit in whole bloodOct 15, 14Mar 06, 18[G01N]
9902961 Aptamers inhibiting the enzymatic activity of the MMP-9 proteinDec 30, 14Feb 27, 18[C12N, A61Q, A61K]
9895380 Methods and pharmaceutical compositions for the treatment of hepatitis B virus infectionSep 10, 14Feb 20, 18[A61K]
9889193 Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (MV-deltaC virus) in cancer therapyJan 20, 14Feb 13, 18[C12N, A61K]
9878016 IGFBP-3 derivatives and uses thereofJun 25, 15Jan 30, 18[G01N, A61K, C07K]
9879320 Combination of biomarkers for the prognosis of response or non-response to an anti-HCV treatmentFeb 09, 12Jan 30, 18[C12Q, G06F, G01N]
9879325 Method for predicting the responsiveness a patient to a treatment with an anti-CD20 antibodyFeb 27, 15Jan 30, 18[C12Q, G01N, A61K, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0224,638 METHODS FOR THE TREATMENT OF TINNITUS INDUCED BY COCHLEAR EXCITOTOXICITYAbandonedSep 07, 16Aug 10, 17[A61K]
2017/0137,419 DERIVATIVES OF 2H-PYRAZOLO[4,3-C]QUINOLIN-3(5H)-ONE AND USE THEREOFAbandonedJun 11, 15May 18, 17[C07D]
2017/0128,564 POLYPEPTIDE DERIVED FROM gp41, A VACCINE COMPOSITION COMPRISING SAID POLYPEPTIDE, AND USES FOR TREATING AN INFECTION BY AN HIV VIRUS IN AN INDIVIDUALAbandonedNov 23, 16May 11, 17[A61K, C07K]
2017/0079,970 TETRAHYDROQUINOLINE DERIVATIVES AND THEIR USE AS EPAC1 INHIBITORS FOR THE TREATMENT OF MYOCARDIAL INFARCTION INJURYAbandonedMar 20, 15Mar 23, 17[A61K]
2017/0056,500 FKBP52-Tau Interaction as a Novel Therapeutical Target for Treating the Neurological Disorders Involving Tau DysfunctionAbandonedOct 27, 16Mar 02, 17[G01N, A61K]
2017/0015,719 CHIMERIC POLYPEPTIDE COMPRISING THE FRAGMENT B OF SHIGA TOXIN AND PEPTIDES OF THERAPEUTIC INTERESTAbandonedJul 26, 13Jan 19, 17[A61K, C07K]
2017/0000,846 USE OF A NEUROFILAMENT PEPTIDE FOR THE TREATMENT OF GLIOMAAbandonedAug 05, 16Jan 05, 17[A61K]
2017/0000,849 CD300A RECEPTORS AS VIRUS ENTRY COFACTORSAbandonedDec 19, 14Jan 05, 17[C12N, A61K, C07K]
2016/0368,975 METHODS AND COMPOSITIONS FOR THE TREATMENT OF BETA-THALASSEMIAAbandonedMay 23, 16Dec 22, 16[A61K, G01N, C07K]
2016/0369,348 METHODS FOR DIAGNOSING AND TREATING MYHRE SYNDROMEAbandonedSep 06, 16Dec 22, 16[C12N, C12Q, G01N, C07K]
2016/0312,220 METHOD AND PHARMACEUTICAL COMPOSITION FOR INHIBITING NEURONAL REMODELINGAbandonedDec 10, 14Oct 27, 16[C12N]
2016/0304,881 DDR1 ANTAGONIST OR AN INHIBITOR OF DDR1 GENE EXPRESSION FOR USE IN THE PREVENTION OR TREATMENT OF CRESCENTIC GLOMERULONEPHRITISAbandonedJul 01, 16Oct 20, 16[C12N, C07K]
2016/0296,595 A RHO GTPASE ACTIVATOR FOR USE AS ANTIMICROBIAL AGENTAbandonedNov 14, 14Oct 13, 16[A61K]
2016/0296,483 Methods and Pharmaceutical Compositions for Treatment of Cystic FibrosisAbandonedJun 06, 16Oct 13, 16[A61K]
2016/0281,176 METHOD FOR PREDICTING THE OUTCOME OF COLON CANCER BY ANALYSING MIRNA EXPRESSIONAbandonedMay 26, 16Sep 29, 16[C12Q]
2016/0257,710 SELECTIVE INHIBITORS OF PROTEINASE 3AbandonedNov 04, 14Sep 08, 16[A61K, G01N, C07K]
2016/0237,158 Methods and Compositions for Targeting Tumor Microenvironment and for preventing MetastasisAbandonedSep 23, 14Aug 18, 16[C12Q, G01N, A61K, C07K]
2016/0230,190 Lentiviral Vectors Having a Mutated Integrase Protein and uses ThereofAbandonedSep 17, 14Aug 11, 16[C12N, A61K]
2016/0230,232 FIBROSIS SUSCEPTIBILITY GENE AND USES THEREOFAbandonedFeb 16, 16Aug 11, 16[C12Q]
2016/0213,701 METHODS AND COMPOSITIONS FOR TREATMENT OF RETINAL DEGENERATIVE DISEASESAbandonedApr 06, 16Jul 28, 16[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.